Use of Combination Therapy in IBD

被引：2
|
作者：
Kaplan, Gil [1 ]
Panaccione, Remo [1 ]
机构：
[1] Univ Calgary, Inflammatory Bowel Dis Clin, Div Gastroenterol, Dept Med, Calgary, AB T2N 1N4, Canada
来源：
INFLAMMATORY BOWEL DISEASES | 2008年 / 14卷
关键词：
D O I：
10.1002/ibd.20688
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S219 / S221
页数：3
相关论文
共 50 条
  • [31] Evolving strategies for the use of combination therapy in hypertension
    Alan H. Gradman
    Celso Acevedo
    Current Hypertension Reports, 2002, 4 : 343 - 349
  • [32] Evolving strategies for the use of combination therapy in hypertension
    Gradman, AH
    Acevedo, C
    CURRENT HYPERTENSION REPORTS, 2002, 4 (05) : 343 - 349
  • [33] Combination therapy in epilepsy - When and what to use
    Kwan, Patrick
    Brodie, Martin J.
    DRUGS, 2006, 66 (14) : 1817 - 1829
  • [34] THE USE OF NIFEDIPINE IN COMBINATION THERAPY FOR THE MANAGEMENT OF HYPERTENSION
    WATHEN, CG
    HANNAN, WJ
    TURNBULL, LW
    ROULSTON, JE
    MUIR, AL
    CLINICAL SCIENCE, 1984, 66 (02) : P66 - P66
  • [35] State of the art: IBD therapy and clinical trials in IBD
    Isaacs, KL
    Lewis, JD
    Sandborn, WJ
    Sands, BE
    Targan, SR
    INFLAMMATORY BOWEL DISEASES, 2005, 11 : S3 - S12
  • [36] COMBINATION THERAPY OF VEDOLIZUMAB AND TOFACITINIB IN IBD PATIENTS WITH CHRONIC ACTIVE REFRACTORY DISEASE COURSE AND SPONDYLARTHRITIS
    Kuehbacher, Tanja
    Leick, Angele
    Vongogh, Gwendolyn
    Porthun, Markus
    Schreiber, Stefan
    Cederqvist, Marco
    GASTROENTEROLOGY, 2019, 156 (06) : S881 - S881
  • [37] Anti-Tumor Necrosis Factor-α Monotherapy Versus Combination Therapy with an Immunomodulator in IBD
    Dulai, Parambir S.
    Siegel, Corey A.
    Peyrin-Biroulet, Laurent
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (03) : 441 - +
  • [38] Infliximab Trough Level or Combination Immunomodulator Therapy: Which Correlates Best With Mucosal Healing in IBD?
    Al-Bawardy, Badr
    Jenkins, Sarah
    Snyder, Melissa
    Loftus, Edward V., Jr.
    Willrich, Maria
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S397 - S397
  • [39] Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
    Dulai, Parambir S.
    Siegel, Corey A.
    Colombel, Jean-Frederic
    Sandborn, William J.
    Peyrin-Biroulet, Laurent
    GUT, 2014, 63 (12) : 1843 - 1853
  • [40] Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy
    Seinen, Margien L.
    van Asseldonk, Dirk P.
    de Boer, Nanne K.
    Bouma, Gerd
    van Nieuwkerk, Carin M.
    Mulder, Chris J.
    Bloemena, Elisabeth
    van Bodegraven, Adriaan A.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (03) : 448 - 452
12345